Achieve Life Sciences, Inc.
- ACHV
- NASDAQ
- Biotechnology
- Biotech
- Healthcare
$6.67
Today +4.62%Quote Oct 19, 2026, 04:59 PM UTC
−19.34%over the last month
Max drawdown −21.4%From 1-month high −21.4%3 months +2.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Achieve Life Sciences
Achieve Life Sciences, Inc. operates as a clinical-stage pharmaceutical firm, concentrating on the development and market introduction of cytisinicline. This compound is aimed at assisting with smoking cessation and nicotine dependence, with commercial activities spanning Canada, the United States, and the United Kingdom.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
28
Market value
$686.9M
Quote Oct 19
Floor
$6.59
1.3% below price
Resistance
$7.00
4.9% above price
Price vs analyst targets
6 analysts
Lowest target
$12.00Highest target
$18.00
$12.00Highest target
$18.00
- Price $6.67
- Average target $14.80
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 122% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ACHVPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free